DataMeds AI files draft information statement on preferred stock authorization

Reuters2026/08/31 21:28

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

DataMeds AI shareholder authorization clears an amendment to create 1,000,000 shares of blank-check preferred stock.
Board slated to designate 25,000 shares as Series A Convertible Preferred Stock tied to May 2026 Notes.
May 2026 Notes total USD 21.13 million principal; mandatory conversion would issue 21,133 Series A preferred shares at USD 1,000 stated value.
Series A terms include 10% dividend accrual starting six months post-issuance; conversions into common stock subject to a 9.99% beneficial ownership cap.
Shareholders also authorized the election of five directors, a share-issuance approval tied to Silverback Capital, and auditor ratification for 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DataMeds AI Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-040878), on August 31, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

DataMeds AI files draft information statement on preferred stock authorization

You may also like

Crypto prices